Colgate-Palmolive Company (NYSE:CL) will release earnings results for its second quarter, before the opening bell on Friday, Jan. 30.
Analysts expect the New York-based company to report quarterly earnings at 91 cents per share, versus 91 cents per share in the year-ago period. The consensus estimate for Colgate-Palmolive's quarterly revenue is $5.12 billion, versus $4.94 billion a year earlier, according to data from Benzinga Pro.
On Oct. 31, the consumer products giant reported third-quarter adjusted earnings per share of 91 cents, beating the analyst consensus estimate of 89 cents. Quarterly sales of $5.131 billion were in line with the Street view. Net sales rose 2% in the latest period.
Colgate-Palmolive shares gained 0.3% to close at $85.24 on Thursday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- JP Morgan analyst Andrea Teixeira maintained an Overweight rating and raised the price target from $88 to $93 on Jan. 16, 2026. This analyst has an accuracy rate of 60%.
- UBS analyst Peter Grom maintained the stock with a Buy rating and raised the price target from $90 to $93 on Jan. 14, 2026. This analyst has an accuracy rate of 60%.
- Wells Fargo analyst Chris Carey upgraded the stock from Underweight to Equal-Weight and boosted the price target from $77 to $86 on Jan. 13, 2026. This analyst has an accuracy rate of 61%.
- TD Cowen analyst Robert Moskow maintained a Buy rating and cut the price target from $90 to $86 on Jan. 8, 2026. This analyst has an accuracy rate of 65%.
- Piper Sandler analyst Michael Lavery upgraded the stock from Neutral to Overweight and boosted the price target from $82 to $88 on Jan. 7, 2026. This analyst has an accuracy rate of 63%.
Considering buying CL stock? Here’s what analysts think:
Photo via Shutterstock